By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Shire Pharmaceuticals Group plc 

Hampshire International Business Park
Basingstoke  Hampshire  RG24 8EP  United Kingdom
Phone: 44-1256-894-000 Fax: 44-1256-894-708



Company News
Shire (SHPG) Delivers Strong Q1 2016 Results With Double-Digit Growth In Revenue And Non GAAP Earnings Per ADS 4/29/2016 8:05:25 AM
Shire (SHPG) To Participate At The Deutsche Bank (DB) 41st Annual Health Care Conference 4/27/2016 10:26:37 AM
ImmunoGen (IMGN) Taps Former Shire (SHPG) Exec as New CEO 4/26/2016 6:15:37 AM
Baxalta (BXLT) Announces Date For Special Meeting Of Stockholders To Vote On Combination With Shire (SHPG) 4/15/2016 9:51:06 AM
Shire (SHPG)'s $400 Million Commitment to Create 400 New Jobs in Ireland 4/15/2016 6:49:27 AM
Shire (SHPG) Submits NDA To FDA For New Formulation Of Vyvanse (Lisdexamfetamine Dimesylate) CII As Chewable Tablets 4/14/2016 6:22:37 AM
Shire (SHPG) Not Spooked by Pfallergan Breakup, Remains Committed to Baxalta (BXLT) 4/7/2016 7:50:01 AM
Shire (SHPG) Announces Positive Results Of SHP465 Safety And Efficacy Study In Children And Adolescents With ADHD 4/4/2016 10:00:19 AM
Shire (SHPG) Wins Patent Trial Against Watson Pharmaceuticals, Inc. (WPI) Concerning LIALDA 3/29/2016 8:17:13 AM
Booming Shire (SHPG) Expands Massachusetts Footprint by Leasing Two Ex-Cubist (MRK) Buildings 3/11/2016 3:10:04 PM